SEC Filing Update: #CLDX Celldex Therapeutics, Inc. : $41.16

Sector: Healthcare | YTD: 🔼+ 52.33% The SEC disclosed Today (14-AUG-2026) that Kynam Capital Management, LP has DECREASED #CLDX Shares by -100.00% 🔴 PRICE T ROWE ASSOCIATES INC MD also reported an increase in its holdings on the same day. * Previous Holdings: 5.32M Shares * Current Holdings: 0.00 Shares * Decrease -5.32M * Decreased (%)-100.00% * Ownership: 6.78% https://www.thinksabio.com/reports/isr/CLDX The quarterly average prices of #CLDX: Q3 2025: $23.18 Q4 2025: $26.35 Q1 2026: $27.27 📌 Institutional activity in the last 30 days for #CLDX: • PRICE T ROWE ASSOCIATES INC MD – Increased holdings by 964 shares (14-AUG-2026)